Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 May 12:167–176. doi: 10.1007/978-981-15-1761-7_6

Tylophorine: Sources, Properties, Applications and Biotechnological Production

Angeline Cyriac 2, Toji Thomas 2, T Dennis Thomas 3,
Editor: Mallappa Kumara Swamy*
PMCID: PMC7211505

Abstract

Tylophora indica, a medicinal climber, belongs to the family, Asclepiadaceae. Roots and leaves of the plant contain several alkaloids including tylophorine, tylophorinine and tylophrinidine. The major alkaloid, tylophorine found in T. indica possesses several properties, such as immunosuppressive, antitumour, antifeedant, antibacterial, antifungal, antiamoebic, diuretic and hepatoprotective activities. In addition to this, tylophorine provides positive stimulation to adrenal cortex. Biotechnological production of tylophorine was fulfilled by inducing hairy roots mediated by Agrobacterium rhizogenes (A4 strain). It was followed by its growth in liquid suspension culture that could yield maximum biomass and tylophorine production. This type of liquid suspension culture yielded 9.8 ± 0.21 mgL−1 tylophorine within 4–6 weeks of incubation. Maceration technique employed for the extraction of tylophorine was the most viable and efficient protocol. Although many reports are available regarding the biotechnological production of tylophorine, its competent and economic production still continues as a problematic issue.

Keywords: Alkaloid, Asclepiadaceae, Secondary metabolites, Tylophora, Tylophorine

Introduction

Tylophora indica (Burm. f.) Merr. resides in Asclepiadaceae of angiosperm family. The plant is a curative climber originally established in the plain and hilly areas of forest found in the Eastern and Southern India extending to an elevation of 900 m. Various synonyms of the plant include Cynanchum indicum Burm. f., T. asthmatica (L. f.) Wight and Arn. in Wight, Asclepias asthmatica L. f. and A. prolifera Rottl. ex Ainslie. Its common English name is ‘emetic swallow-wort’ (Sasidharan 2004). Due to its excessive medicinal use, attempts were made to standardize micropropagation protocols in this plant by using different explants (Thomas and Philip 2005; Thomas 2006, 2009). Plant secondary metabolites are chemical compounds having negligible function in the perpetuation of fundamental life activities in plants which manufacture it. However, it has crucial task in the intercommunication of the plant with its habitat. The synthesis of these compounds is usually a little (less than 1% dry weight), and it has tremendous influence on the physiological and developmental state of the plant (Dixon 2001; Oksman-Caldentey and Inzé 2004). The major alkaloid present in T. indica is phenanthroindolizidine type, and its heterocyclic ring consists of indolizidine ring fused to a phenanthrene ring. This alkaloid was isolated and named as ‘tylophorine’ by Ratnagiriswaran and Venkatachalam (1935) for the first time. Along with tylophorine, they had isolated alkaloid ‘tylophorinine’ also from the aerial parts of T. indica. The roots and foliage of the plant yield 0.2–0.46% tylophorine, tylophorinine and tylophrinidine (Gopalakrishnan et al. 1979). The plant is conventionally employed for the medication of several respiratory disorders such as bronchitis, seasonal cough and cold, hay fever and asthma (Haranath and Shayamalakumari 1975; Gupta et al. 1979; Rao et al. 1980). The roots along with leaves of the plant are further employed to alleviate jaundice and liver disorders (Devprakash et al. 2012). Tylophorinine, a minor alkaloid, was isolated and characterized from T. asthmatica by Govindachari et al. (1961). Dhiman et al. (2013) isolated and characterized a novel phenanthroindolizidine alkaloid, 3-O-demethyl tylophorinidine (VI), from the leaves and stems of T. indica by utilizing various chromatographic and spectroscopic techniques. Zhen et al. (2002) reported that phenanthroindolizidine alkaloids like tylophoridicine A, O-methyl tylophorinidine and tylophorinidine possessed prominent anticancer activity towards different cell lines.

Sources and Chemistry of Tylophorine

Ratnagiriswaran and Venkatachalam (1935) separated and quantified tylophorine and tylophorinine from T. asthmatica (syn. T. indica). These compounds were segregated through fractional crystallization of the composite salts. Rao and Brook (1970) extracted biologically efficacious alkaloids including tylophorine from T. indica and T. dalzellii by acid extraction succeeded by solvent distillation utilizing methanol followed by ethyl acetate and chloroform. Viswanathan and Pai (1985) analysed the chemical constituents in T. mollissima and isolated caffeine alkaloid as a greater constituent, along with tylophorine and tylophorinine, a lesser content alkaloids. The compounds were characterized by different spectroscopic techniques. Govindachari (2002) separated and quantified tylophorinidine, tylophorine, tylophorinine, septicine and isotylocrebrine by chromatographic method utilizing alumina. They had reviewed the structure of tylophorinine and tylophorinidine through X-ray scrutiny. It is believed that the presence of several alkaloids including tylophorine in the form of secondary metabolites in Tylophora resulted in its high medicinal value in herbal medicine.

Tylophorine (C24H27NO4) is a bioactive secondary metabolite present in T. indica (Fig. 1). It contains organonitrogen heterocyclic and organic heteropentacyclic compounds. Its IUPAC name is (13as)-2,3,6,7-tetramethoxy-9,11,12,13,13a,14-hexahydrophenanthro[9,10-f] indolizine. It has a tertiary base with a 2,3,6,7-methoxyl-substituted phenanthrene ring system and is joined with an indolizidine ring in its 9,10-position. The molecular formula of this compound is C24H27NO4. The molecular weight of tylophorine is 393.194008 g/mol. Elemental analysis showed C 73.26%, H 6.92%, N 3.56% and O 16.26% as the percentage composition of various elements (Ali and Butani 1989). The related compounds include tylophorinine and tylophrinidine (Fig. 1).

Fig. 1.

Fig. 1

Chemical structures of prominent alkaloids from Tylophora indica

The IUPAC name of tylophorinine (C23H25NO4) compound is (13aS,14R)-3,6,7-trimethoxy-9, 11, 12, 13, 13a, 14-hexahydrophenanthro [9, 10-f] indolizin-14-ol. The molecular weight of tylophorinine is 379.400 g/mol (Mulchandani et al. 1971). The IUPAC name of tylophrinidine (C22H22NO4) is (13aS,14S)-3,7-dimethoxy-9, 11, 12, 13, 13a, 14-hexahydrophenanthro [10, 9-f] indolizine-6, 14-diol, and the molecular weight is 365.4 g/mol (Mulchandani et al. 1971).

Bioactive Properties and Application of Tylophorine

Family Asclepiadaceae produces phenanthroindolizidine alkaloids as major secondary metabolites. The phenanthroindolizidine alkaloids are considered as extremely important phytochemical due to its intense cytotoxic effect. This is due to its role in the prevention of the synthesis of DNA and proteins (Rao et al. 1997, 1998; Abe et al. 1998; Rao and Venkatachalam 2000). The properties and bioactivities of tylophorine has been well investigated (Table 1). Tylophorine possesses antiproliferative action in cancer cells; it rapidly diminishes cyclin D1, reduces protein biosynthesis and prevents vascular smooth muscle cell proliferation in vitro (Joa et al. 2019). Apoptosis could be mediated by unique application of tylophorine or tylophorine plus doxorubicin in T47D breast cancer cells; this happened because it regulated the expression of genes of caspases 3 and 9 (Pratama et al. 2018). Wang et al. (2017) communicated that tylophorine analogues like DCB-3503 and rac-cryptopleurine could interrupt hepatitis C virus multiplication. The tylophorine-assisted downregulation of cyclin A2 protein levels resulted in primary G1 arrest. Chromatin immunoprecipitation studies disclosed that tylophorine induced c-Jun downregulation of the cyclin A2 promoter activity (Yang et al. 2013). Tylophorine could induce anti-angiogenesis effects via VEGFR2 signalling pathway and acts as a suitable drug candidate for anti-angiogenesis and anticancer therapies (Saraswati et al. 2013). According to Niphakis et al. (2012), tylophorine alkaloid has remarkable antiproliferative properties. The efficiency of tylophorine compounds as a unique and vigorous anti-coronavirus factor as well as the probability to develop it into therapeutic agents for alleviating transmittable gastroenteritis virus (TGEV) or severe acute respiratory syndrome coronavirus (SARS CoV) infection has been reported by Yang et al. (2010).

Table 1.

A brief summary of various in vitro bioactivity studies of tylophorine

Biological activity of tylophorine References
Antiproliferative action in cancer cells Joa et al. (2019)
Anticancer activity Pratama et al. (2018); Yang et al. (2013); Saraswati et al. (2013); Niphakis et al. (2012); Wang et al. (2010b); Wei et al. (2006)
Anti-inflammatory action Lee et al. (2011); Yang et al. (2009a); Wen et al. (2014)
Cytotoxic activity Yang et al. (2009b)
Positive stimulant to adrenal cortex Udupa et al. (1991)
Antifeedant activity Reddy et al. (2009)
Antiviral activities Wang et al. (2010a); Yang et al. (2010); Wang et al. (2017)
Antibacterial Reddy et al. (2009)
Antiamoebic action Bhutani et al. (1985)
Antifungal Reddy et al. (2009)
Hepatoprotective activity Gujrati et al. (2007)
Anti-allergic activity Nayampalli and Sheth (1979); Ganguly et al. (2001)
Anti-angiogenic Saraswati et al. (2013)
Diuretic activity Meera et al. (2009)
Inhibition of cellular immune responses Ganguly and Sainis (2001)
Therapeutic agent for inflammatory arthritis You et al. (2006)

DCB-3503 is an analogue of tylophorine; it arrests the multiplication of PANC-1 (human pancreatic ductal cancer cell line) and HepG2 (human hepatocellular cancer cell line) tumour found in mice. The mechanism of action of inhibition is cell differentiation, and there is no cell death. Nevertheless, the exact role played by tylophorine analogue is obscure. Tylophorine analogue, DCB-3503, can repress translation, and therefore the mode of functioning is dissimilar with other available anticancer molecules as it interferes with protein synthesis (Wang et al. 2010a). In another study conducted by Wang et al. (2010b), several C9-substituted phenanthrene-based tylophorine derivatives were made in the lab and evaluated its antiviral properties towards tobacco mosaic virus (TMV). The properties of synthesized compounds were comparable to that of the alkaloid tylophorine. Yang et al. (2009a) observed potent cytotoxic activity for new nine-substituted phenanthrene-based tylophorine analogues. Tylophorine exhibited higher antifeedant activity as compared to septicine, O-methyl tylophorinidine and simple aliphatic acid, isolated from T. indica. These pure compounds showed prominent antibacterial action at lower concentrations to several bacterial strains tested other than E. coli. At the same time, pure compounds demonstrated antifungal action against Aspergillus niger, A. fumigatus and Trichoderma viride (Reddy et al. 2009). Tylophorine can provide positive stimulant to adrenal cortex (Udupa et al. 1991). According to Bhutani et al. (1985), tylophorine exhibits antiamoebic action. Hepatoprotective activity was demonstrated in alcoholic and aqueous distillate of T. indica foliages, which contained tylophorine (Gujrati et al. 2007). Anti-allergic activity was demonstrated for tylophorine and other related alkaloids. This action is mainly due to immunosuppressive effects, direct bronchodilator and membrane stabilizing properties (Nayampalli and Sheth 1979). Aqueous as well as alcoholic leaf extracts of T. indica revealed prominent diuretic action (Meera et al. 2009). Tylophora alkaloids suppressed contact sensitivity towards dinitrofluorobenzene in mice as it was treated just before or after contact sensitization (Ganguly et al. 2001). Anti-inflammatory activity was reported by phenanthroindolizidine alkaloids, such as tylophorine and ficuseptine A (Yang et al. 2009a).

Biotechnological Production of Tylophorine

Agrobacterium-Mediated Transformation and Tylophorine Production

The Gram-negative bacterium Agrobacterium rhizogenes is usually present in soil which can infect higher plants and produce genetically modified roots. During transformation, the bacteria transfers T-DNA—a 25-bp oligonucleotide repeat—from its root inducing (Ri) plasmid to the genome of the affected plant. During this process, the plant can produce fine hair-like roots known as ‘hairy roots’ at the location of infective spot. This protocol is regarded as one of the most feasible ways of producing useful secondary metabolites without destroying the natural plants. It can provide continuous supply of desired secondary metabolites within a brief period. Chaudhuri et al. (2005) standardized a technique for the transgenic root production in T. indica using A. rhizogenes (LBA 9402 and A4 strains). A. rhizogenes were used to infect the leaves, stems and intact shoots, and calli and roots were induced from such explants at various sites. The response was mainly depending on factors like type of strains used, type explant and the infection sites. Only one strain (i.e. A4) responded and induced transformation. The maximum frequency of transformation was 60% with intact shoots. The transformed nature of the roots was confirmed by PCR analysis. The tylophorine production varied considerably in various root clones analysed. Roots attained maximum biomass and tylophorine yield in 4–6 weeks of suspension culture. The tylophorine extraction was performed by the modified method of Abe et al. (1995). Roots were dried, powdered and defatted with petroleum ether for 24 h. Further extraction was carried out by using 25-mL chloroform by cold percolation for 24 h. This was performed thrice, and all the extracts were combined and dried by evaporation. The 5-mL residual medium was extracted thrice using chloroform (10 mL) by continuous stirring for about 2 h, and the chloroform portions were isolated by a separating funnel. All the fractions were pooled together, dried and resuspended in a 5-mL mobile phase and filtered using a millipore filter (0.2 mm). High-performance liquid chromatography (HPLC) analysis of the transformed roots was performed, and the maximum tylophorine yield was obtained in clone numbers 5 and 41 (1.29 ± 0.02 and 1.29 ± 0.5 mg/g DW), respectively.

Extraction from Dried Leaves, Callus and Suspension Cultures

Anand et al. (2012) isolated tylophorine from the leaves, callus and suspension cultures of Tylophora spp. The protocol employed was cold extraction with acetic acid in methanol, followed by acid extraction with acetic ethyl acetate. Leaf-derived callus (1.0 g) was maintained in MS medium (about 100 mL) containing plant growth regulators in a 250-mL conical flask and placed on a shaker with 120 rpm. The biomass observations were done every 3 days. The leaves collected from field-grown plants were dried and ground to fine powder before processing. The protocol was employed by Rao and Brook (1970) for further processing. Further, extraction protocol employed was cold extraction with acetic acid in methanol, followed by acid extraction with ethyl acetate and HCl. High-performance thin-layer chromatography (HPTLC) technique was used to separate tylophorine, and the samples were confirmed with the presence of tylophorine in comparison with the Rf value of test samples as that of standard. The outcome of HPTLC result indicated seven dissimilar peaks, of which the seventh one is confirmed as tylophorine. The quantitative analysis was done by analysing the peak area and standard concentration. Of the three different sources employed for quantitative analysis of tylophorine, leaf extract exhibited maximum (yield 80 μg/mL), followed by leaf callus (yield 24.46 μg/mL) and suspension extract (28.30 μg/mL). In another similar work by the same authors, Kaur et al. (2011) studied the tylophorine content in leaves of T. indica. The collected foliage was washed in free-flowing tap water. Further, leaves were dried and ground to clear powder using a mortar and pestle. To remove the oil-soluble components, the leaf powder was washed twice with hexane. Further, to extract components in the acetate layer, it was soaked overnight in ethyl acetate. The pH of the filtered extract was maintained at 3–4 with HCl. Distilled water (100 mL) was added to dilute the extract and then concentrate it to half of its volume by using a flash evaporator at 55–60 °C. Dichloromethane was used to wash the extract three times, and the pH was adjusted from 11 to 13 by using NaOH. Flash evaporator was used to concentrate the extract and was resuspended in chloroform for HPTLC analysis. With the help of a 100-μL syringe, the plant extract was applied on precoated silica gel plates (10 × 10 cm) with a band length of 8 mm and a track separation of 12 mm. Toluene/chloroform/ethanol/ammonia (4:3.5:1.5 drop) was used as solvent system and scanned at 258-nm wave length. The quantitate estimation of tylophorine was done by the following formula:

Concentrationμg/mL=Areaofpeakofstandardintestsample×Concentrationofstandard/Areaofstandardpeak

Densitometry evaluation at 258 nm showed seven different bands including tylophorine with Rf 0.68 and 81.42% area. The quantitative estimation showed a yield of 80 μg/mL tylophorine.

Extraction Using Maceration Method

Gupta et al. (2012) developed an experimental procedure for the extraction of tylophorine. This protocol is called maceration method. The extraction experiments were carried out by using various solvents like ethanol (95%), chloroform and sulphuric acid (2%). Hot extraction was carried out with 95% alcohol with various concentrations of glacial acetic acid and citric acid. The defatting of the sample was carried out with petroleum ether and subsequently macerated with 95% alcohol. The extract thus obtained was concentrated to one-fourth volume by using a rotary vacuum evaporator. Further purification was done by acid-base purification technique. Both alkaloid and standard were compared by thin-layer chromatography in order to confirm the presence of tylophorine. The alkaloid tylophorine was characterized by using various techniques like IR, UV, NMR and mass spectroscopy. The alkaloid was further examined by HPLC technique to find out its tylophorine content. Of the various techniques used for tylophorine extraction, hot extraction with 95% alcohol containing 2% citric acid gave the best yield. Here the total alkaloid content, tylophorine content and total tylophorine yield were 0.280 g, 17.25 (%w/w) and 0.0483 g, respectively. The reason for highest yield in this treatment was due to the reaction of alkaloids with acid and the subsequent formation of salts which is more soluble in 95% alcohol, and therefore higher yield was obtained. Therefore, it was concluded that this protocol is most effective and could be used for the commercial extraction of tylophorine.

Conclusions

Tylophorine is an alkaloid obtained from T. indica. In addition, the plant contains tylophorinine, tylophrinidine, septicine and isotylocrebrine. Major alkaloid tylophorine possesses many properties including immunosuppressive, antitumour, antifeedant, antibacterial, antifungal, antiamoebic, diuretic and hepatoprotective activities. As an important alkaloid, it has different potential medical applications. Although various methods have been standardized for the biotechnological production and extraction of tylophorine, an efficient and cost-effective protocol still needs to be standardized. Moreover, the quantitative improvement of tylophorine still remains as a challenge.

Contributor Information

Mallappa Kumara Swamy, Email: swamy.bio@gmail.com.

T. Dennis Thomas, Email: den_thuruthiyil@yahoo.com.

References

  1. Abe F, Iwase Y, Yamauchi T, Honda K, Hayashi N. Phenanthroindolizidine alkaloids from Tylophora tanakae. Phytochemistry. 1995;39:695–699. doi: 10.1016/0031-9422(95)00034-5. [DOI] [Google Scholar]
  2. Abe F, Hirokawa M, Yamauchi T, Honda K, Hayashi N, Ishii M, Imagawa S, Iwahana M. Further investigation of phenanthroindolizidine alkaloids from Tylophora tanakae. Chem Pharm Bull. 1998;46:767–769. doi: 10.1248/cpb.46.767. [DOI] [PubMed] [Google Scholar]
  3. Ali M, Butani KK. Alkaloids from Tylophora indica. Phytochemistry. 1989;28:3513–3517. doi: 10.1016/0031-9422(89)80376-0. [DOI] [Google Scholar]
  4. Anand M, Kaur H, Goyal D (2012) A micropropagation system for Tylophora Indica and extraction and purification of tylophorine from cultures and in vitro regenerated plants. In: International conference on environmental, biomedical and biotechnology, IACSIT Press, Singapore, pp 14–17
  5. Bhutani KK, Sharma GL, Sarin AN, Kaur R, Kumar V, Atal CK. In vitro amoebicidal and bactericidal activities in medicinal plants. Indian J Pharm Sci. 1985;47:65–67. [Google Scholar]
  6. Chaudhuri KN, Ghosh B, Tepfer D, Jha S. The root: a potential new source of competent cells for high-frequency regeneration in Tylophora indica. Plant Cell Rep. 2005;24:25–35. doi: 10.1007/s00299-004-0904-x. [DOI] [PubMed] [Google Scholar]
  7. Devprakash SG, Senthilkumar GP, Tembare R, Mani T. GC-MS analysis of Tylophora indica. Int J Pharm Res Dev. 2012;4:222–224. [Google Scholar]
  8. Dhiman M, Khanna A, Manju SL. A new phenanthroindolizidine alkaloid from Tylophora indica. Chem Pap. 2013;67:245–248. doi: 10.2478/s11696-012-0265-9. [DOI] [Google Scholar]
  9. Dixon RA. Natural products and plant disease resistance. Nature. 2001;411:843–847. doi: 10.1038/35081178. [DOI] [PubMed] [Google Scholar]
  10. Ganguly T, Sainis KB. Inhibition of cellular immune responses by Tylophora indica in experimental models. Phytomedicine. 2001;8:348–355. doi: 10.1078/0944-7113-00055. [DOI] [PubMed] [Google Scholar]
  11. Ganguly T, Badheka LP, Sainis KB. Immunomodulatory effect of Tylophora indica on Con A induced lymphoproliferation. Phytomedicine. 2001;8:431–437. doi: 10.1078/S0944-7113(04)70061-6. [DOI] [PubMed] [Google Scholar]
  12. Gopalakrishnan C, Shankaranarayan D, Kameswaran L, Natarajan S. Pharmacological investigations of tylophorine, the major alkaloid of Tylophora indica. Indian J Med Res. 1979;69:513–520. [PubMed] [Google Scholar]
  13. Govindachari TR. Five decades in the study of natural products. Proc Indian Acad Sci (Chem Sci) 2002;114:175–195. doi: 10.1007/BF02704262. [DOI] [Google Scholar]
  14. Govindachari TR, Pai BR, Ragade IS, Rajappa S, Viswanathan N. Chemical examination of Tylophora asthmatica—V: structure of tylophorinine. Tetrahedron. 1961;14:288–295. doi: 10.1016/S0040-4020(01)92178-7. [DOI] [Google Scholar]
  15. Gujrati V, Patel N, Rao VN, Nandakumar K, Gouda TS, Shalam MD, Kumar SM. Hepatoprotective activity of alcoholic and aqueous extract of leaves of Tylophora indica in rats. Indian J Pharmacol. 2007;39:43–47. doi: 10.4103/0253-7613.30763. [DOI] [Google Scholar]
  16. Gupta S, George P, Gupta V. Tylophora indica in bronchial asthma—a double blind study. Indian J Med Res. 1979;69:981–989. [PubMed] [Google Scholar]
  17. Gupta R, Datta A, Shri R. Extraction process optimization of tylophorine from Tylophora asthmatica Wight & Arn. Pharmacogn J. 2012;4:19–23. doi: 10.5530/pj.2012.28.4. [DOI] [Google Scholar]
  18. Haranath PS, Shayamalakumari S. Experimental study on mode of action of Tylophora asthmatica in bronchial asthma. Indian J Med Res. 1975;63:661–670. [PubMed] [Google Scholar]
  19. Joa H, Blažević T, Grojer C, Zeller I, Heiss EH, Atanasov AG, Feldler I, Gruzdaitis P, Czaloun C, Proksch P, Messner B, Bernhard D, Dirsch VM. Tylophorine reduces protein biosynthesis and rapidly decreases cyclin D1, inhibiting vascular smooth muscle cell proliferation in vitro and in organ culture. Phytomedicine. 2019;60:152938–152943. doi: 10.1016/j.phymed.2019.152938. [DOI] [PubMed] [Google Scholar]
  20. Kaur H, Anand M, Goyal D. Extraction of tylophorine from in vitro raised plants of Tylophora indica. J Med Plants Res. 2011;5:729–734. [Google Scholar]
  21. Lee YZ, Huang CW, Yang CW, Hsu HY, Kang IJ, Chao YS, Chen IS, Chang HY, Lee SJ. Isolation and biological activities of phenanthroindolizidine and septicine alkaloids from the Formosan Tylophora ovata. Planta Med. 2011;77:1932–1938. doi: 10.1055/s-0030-1271199. [DOI] [PubMed] [Google Scholar]
  22. Meera R, Devi P, Muthumani P, Kameswari B, Eswarapriya B. Evaluation of diuretic activity from Tylophora indica leaves extracts. J Pharm Sci Res. 2009;1:112–116. [Google Scholar]
  23. Mulchandani SB, Iyer SS, Badheka LP. Structure of tylophorinindine a new potential antitumor alkaloid from Tylophora indica. Indian J Chem. 1971;19:505–506. [Google Scholar]
  24. Nayampalli SS, Sheth UK. Evaluation of anti-allergic activity of Tylophora indica using rat lung perfusion. Indian J Pharmacol. 1979;11:229–232. [Google Scholar]
  25. Niphakis MJ, Gay BC, Hong KH, Bleeker NP, Georg GI. Synthesis and evaluation of the anti-proliferative and NF-κB activities of a library of simplified tylophorine analogs. Bioorg Med Chem. 2012;20:5893–5900. doi: 10.1016/j.bmc.2012.07.044. [DOI] [PubMed] [Google Scholar]
  26. Oksman-Caldentey KM, Inzé D. Plant cell factories in the post-genomic era: new ways to produce designer secondary metabolites. Trends Plant Sci. 2004;9:433–440. doi: 10.1016/j.tplants.2004.07.006. [DOI] [PubMed] [Google Scholar]
  27. Pratama NP, Wulandari S, Nugroho AE, Fakhrudin N, Astuti P, Sudarsono Tylophorine abrogates G2/M arrest induced by doxorubicine and promotes increased apoptosis in T47D breast cancer cells. Asian Pac J Cancer Prev. 2018;19:3065–3069. doi: 10.31557/APJCP.2018.19.11.3065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rao VK, Brook P. Alkaloids of Tylophora indica and Tylophora dalzellii. US Patent. 1970;3:497–593. [Google Scholar]
  29. Rao KN, Venkatachalam SR. Inhibition of dihydrofolate reductase and cell growth activity by the phenanthroindolizidine alkaloids pergularinine and tylophorinidine: the in vitro cytotoxicity of these plant alkaloids and their potential as antimicrobial and anticancer agents. Toxicol In Vitro. 2000;14:53–59. doi: 10.1016/S0887-2333(99)00092-2. [DOI] [PubMed] [Google Scholar]
  30. Rao AK, Gore KV, Guruswamy MN. Physiological studies with Tylophora asthmatica in bronchial asthma. Indian J Med Res. 1980;71:144–148. [PubMed] [Google Scholar]
  31. Rao KN, Bhattacharyya RK, Venkatachalam SR. Inhibition of thymidylate synthase and cell growth by the phenanthroindolizidine alkaloids pergularinine and tylophorinidine. Chem-Biol Interact. 1997;106:201–211. doi: 10.1016/S0009-2797(97)00065-3. [DOI] [PubMed] [Google Scholar]
  32. Rao KN, Bhattacharyya RK, Venkatachalam SR. Thymidylate synthase activity in leukocytes from patients with chronic myelocytic leukemia and acute lymphocytic leukemia and its inhibition by phenanthroindolizidine alkaloids pergularinine and tylophorinidine. Cancer Lett. 1998;128:183–188. doi: 10.1016/S0304-3835(98)00061-5. [DOI] [PubMed] [Google Scholar]
  33. Ratnagiriswaran AN, Venkatachalam K. The chemical examination of Tylophora asthmatica and isolation of the alkaloids tylophorine and tylophorinine. Indian J Med Res. 1935;22:433–441. [Google Scholar]
  34. Reddy BK, Balaji M, Reddy PU, Sailaja G, Vaidyanath K, Narasimha G. Antifeedant and antimicrobial activity of Tylophora. Afr J Biochem Res. 2009;3:393–397. [Google Scholar]
  35. Saraswati S, Kanaujia PK, Kumar S, Kumar R, Alhaider AA. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis. Mol Cancer. 2013;12:1–16. doi: 10.1186/1476-4598-12-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sasidharan N. Biodiversity documentation for Kerala: flowering plants. Peechi: Kerala Forest Research Institute; 2004. p. 293. [Google Scholar]
  37. Thomas TD. Effect of gibberellic acid, sugars and abscisic acid on somatic embryogenesis in Tylophora indica (Burm. f.) Merrill. Chinese. J Biotechnol. 2006;22:465–471. doi: 10.1016/s1872-2075(06)60039-3. [DOI] [PubMed] [Google Scholar]
  38. Thomas TD. Isolation, callus formation and plantlet regeneration from mesophyll protoplasts of Tylophora indica (Burm. f.) Merrill: an important medicinal plant. In Vitro Cell Dev Biol Plant. 2009;45:591–598. doi: 10.1007/s11627-008-9190-6. [DOI] [Google Scholar]
  39. Thomas TD, Philip B. Thidiazuron induced high frequency plant regeneration via organogenesis from leaf-derived calli of a medicinal climber, Tylophora indica (Burm. f.) Merrill. In Vitro Cell Dev Biol Plant. 2005;41:124–128. doi: 10.1079/IVP2004575. [DOI] [Google Scholar]
  40. Udupa AL, Upupa SL, Guruswamy MN. The possible site of antiasthmatic action of Tylophora asthmatica on pituitary adrenal axis in albino rats. Planta Med. 1991;57:409–413. doi: 10.1055/s-2006-960136. [DOI] [PubMed] [Google Scholar]
  41. Viswanathan N, Pai BR. Alkaloids of Tylophora mollissima. J Nat Prod. 1985;48:997–998. doi: 10.1021/np50042a026. [DOI] [Google Scholar]
  42. Wang K, Hu Y, Liu Y, Mi N, Fan Z, Liu Y, Wang Q. Design, synthesis, and antiviral evaluation of phenanthrene-based tylophorine derivatives as potential antiviral agents. J Agric Food Chem. 2010;58:12337–12342. doi: 10.1021/jf103440s. [DOI] [PubMed] [Google Scholar]
  43. Wang Y, Gao W, Svitkin YV, Chen AP, Cheng YC. DCB-3503, a tylophorine analog, inhibits protein synthesis through a novel mechanism. PLoS One. 2010;5:1–11. doi: 10.1371/annotation/bc95caf3-62cf-4ecd-8a79-9116e62f4a50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wang Y, Lee S, Ha Y, Lam W, Chen SR, Dutschman GE, Gullen EA, Grill SP, Cheng Y, Fürstner A, Francis S, Baker DC, Yang X, Lee KH, Cheng YC. Tylophorine analogs allosterically regulates heat shock cognate protein 70 and inhibits hepatitis C virus replication. Sci Rep. 2017;7:1–10. doi: 10.1038/s41598-016-0028-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wei L, Brossi A, Kendall R, Bastow KF, Morris-Natschke SL, Shi Q, Lee KH. Antitumor agents 251: synthesis, cytotoxic evaluation, and structure-activity relationship studies of phenanthrene-based tylophorine derivatives (PBTs) as a new class of antitumor agents. Bioorg Med Chem. 2006;14:6560–6569. doi: 10.1016/j.bmc.2006.06.009. [DOI] [PubMed] [Google Scholar]
  46. Wen T, Wang Z, Meng X, Wu M, Li Y, Wu X, Zhao L, Wang P, Yin Z, Li-Ling J, Wang Q. Synthesis of novel tylophorine derivatives and evaluation of their anti-inflammatory activity. ACS Med Chem Lett. 2014;5:1027–1031. doi: 10.1021/ml500255j. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Yang CW, Chen WL, Wu PL, Tseng HY, Lee SJ. Anti-inflammatory mechanisms of phenanthroindolizidine alkaloids. Mol Pharmacol. 2009;69:749–758. doi: 10.1124/mol.105.017764. [DOI] [PubMed] [Google Scholar]
  48. Yang X, Shi Q, Liu YN, Zhao G, Bastow KF, Lin JC, Yang SC, Yang PC, Lee KH. Antitumor agents 268 design, synthesis and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents. J Med Chem. 2009;52:5262–5268. doi: 10.1021/jm9009263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Yang CW, Lee YZ, Kang IJ, Barnard DL, Jan JT, Lin D, Huang CW, Yeh TK, Chao YS, Lee SJ. Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus. Antivir Res. 2010;88:160–168. doi: 10.1016/j.antiviral.2010.08.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Yang CW, Lee YZ, Hsu HY, Wu CM, Chang HY, Chao YS, Lee SJ. c-Jun-mediated anticancer mechanisms of tylophorine. Carcinogenesis. 2013;34:1304–1314. doi: 10.1093/carcin/bgt039. [DOI] [PubMed] [Google Scholar]
  51. You X, Pan M, Gao W, Shiah HS, Tao J, Zhang D, Koumpouras F, Wang S, Zhao H, Madri JA, Baker D, Cheng YC, Yin Z. Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response. Arthritis Rheum. 2006;54:877–886. doi: 10.1002/art.21640. [DOI] [PubMed] [Google Scholar]
  52. Zhen YY, Huang XS, Yu DQ, Yu SS. Antitumor alkaloids isolated from Tylophora ovata. Acta Bot Sin. 2002;44:349–353. [Google Scholar]

Articles from Plant-derived Bioactives are provided here courtesy of Nature Publishing Group

RESOURCES